Click on a topic below to discover related SITC resources about Clinical Data and Practical Considerations. Click on the box again to minimize it.
Journal for ImmunoTherapy of Cancer
The Journal for ImmunoTherapy of Cancer, the official journal of the Society for Immunotherapy of Cancer (SITC), is an open access, peer-reviewed journal with a 2020 impact factor of 13.751.Position article and guidelines: "Society for Immunotherapy of Cancer clinical and biomarkers data sharing resource document: Volume II—practical challenges"READ NOW
Position article and guidelines: “Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lymphoma"
READ NOWPosition article and guidelines: "Defining current gaps in quality measures for cancer immunotherapy: consensus report from the Society for Immunotherapy of Cancer (SITC) 2019 Quality Summit"READ NOW
Live Event: Cytokines in Cancer Immunotherapy Workshop
Oct. 11–12, 2021 • New YorkThe SITC Cytokines in Cancer Immunotherapy Workshop is a two-day program focusing on providing a deeper understanding of cytokines in immune cell proliferation, differentiation, and function, as they pertain to tumor immunobiology and cancer immunotherapy approaches.
View Schedule Register
Annual Meeting & Pre-Conference Programs
The Society for Immunotherapy of Cancer (SITC) Annual Meeting & Pre-Conference Programs brought together stakeholders across the cancer immunotherapy field to advance the science, discover breakthroughs and educate the world on cancer immunotherapy.
Concurrent Session 105: Early Phase 1 Clinical Trials
Concurent Session 302: Clinical Trials
VIEW ALL SITC 2018 MATERIALS
Cancer Immunotherapy Winter School
VIEW ALL 2019 PROGRAM MATERIALS
Journal for Immunotherapy of Cancer
The Journal for ImmunoTherapy of Cancer, the official journal of the Society for Immunotherapy of Cancer (SITC), is an open access, peer-reviewed journal with a 2020 impact factor of 13.751.
ACCESS THE FULL JOURNAL
SITC Consensus Statements, Guidelines and White Papers
SITC's Guide to Managing Immunotherapy Toxicity Textbook
SITC's Guide to Managing Immunotherapy Toxicity is a practical reference to managing side effects associated with U.S. Food and Drug Administration (FDA)-approved cancer immunotherapy treatments. Written by world-recognized thought leaders in the field of cancer immunotherapy, this text provides thorough coverage of the toxicity and management of adverse events experienced during treatment with immune checkpoint inhibitors.
Cancer Immunotherapy Principles and Practice is an authoritative textbook to cancer immunobiology and the immunotherapy treatments that harness the immune system to combat malignant disease. This comprehensive reference work covers all major topics that have shaped the development of immunotherapy and propelled it to its current place at the forefront of cancer treatment innovation.
To check out other online courses and webinars, click the button below.
EXPLORE ALL ONLINE OFFERINGS
Membership: Click here to explore the benefits of being a SITC member
Path to SITC Leadership: Click here to learn various ways to become engaged with SITC
Volunteer: Click here to find out about SITC’s volunteer opportunities
SITC Media Room: Click here to read the latest in cancer immunotherapy via press releases, monthly newsletters and meeting reports
A free SITC CONNECT account is needed to access resources. If you are new to SITC, please click the link below to set up an account.
Meeting highlights The SentinelReturn to Research Resource Page
On September 16, 2021, leading experts from the SITC Immune Checkpoint Inhibitor-related Adverse Events ...
The Journal for ImmunoTherapy of Cancer (JITC) is the official journal of the Society for Immunotherapy ...
On September 15, 2021, leading experts in the cancer immunotherapy field discussed early career scientists, ...
From the Society for Immunotherapy of Cancer (SITC) for clinical oncologists, registered nurses, pharmacists, ...
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com